Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients.

Bazeley J, Bieber B, Li Y, Morgenstern H, de Sequera P, Combe C, Yamamoto H, Gallagher M, Port FK, Robinson BM.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2452-61. doi: 10.2215/CJN.00710111. Epub 2011 Aug 25.

2.

Comparison of C-reactive protein and high-sensitivity C-reactive protein levels in patients on hemodialysis.

Helal I, Zerelli L, Krid M, ElYounsi F, Ben Maiz H, Zouari B, Adelmoula J, Kheder A.

Saudi J Kidney Dis Transpl. 2012 May;23(3):477-83.

3.

Vascular access type, inflammatory markers, and mortality in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study.

Banerjee T, Kim SJ, Astor B, Shafi T, Coresh J, Powe NR.

Am J Kidney Dis. 2014 Dec;64(6):954-61. doi: 10.1053/j.ajkd.2014.07.010. Epub 2014 Sep 27.

4.

Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients.

Hung SC, Hsu TW, Lin YP, Tarng DC.

Clin J Am Soc Nephrol. 2012 Aug;7(8):1257-65. doi: 10.2215/CJN.08410811. Epub 2012 May 24.

5.

Uric acid levels and all-cause and cardiovascular mortality in the hemodialysis population.

Latif W, Karaboyas A, Tong L, Winchester JF, Arrington CJ, Pisoni RL, Marshall MR, Kleophas W, Levin NW, Sen A, Robinson BM, Saran R.

Clin J Am Soc Nephrol. 2011 Oct;6(10):2470-7. doi: 10.2215/CJN.00670111. Epub 2011 Aug 25.

6.

Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremia.

Ha YE, Kang CI, Joo EJ, Joung MK, Chung DR, Peck KR, Lee NY, Song JH.

Korean J Intern Med. 2011 Jun;26(2):195-200. doi: 10.3904/kjim.2011.26.2.195. Epub 2011 Jun 1.

7.

Prognostic values of C-reactive protein levels on clinical outcome after endovascular therapy in hemodialysis patients with peripheral artery disease.

Ishii H, Kumada Y, Toriyama T, Aoyama T, Takahashi H, Murohara T.

J Vasc Surg. 2010 Oct;52(4):854-9. doi: 10.1016/j.jvs.2010.05.020. Epub 2010 Jul 17.

8.

Evidence that C-reactive protein or IL-6 are not surrogates for all inflammatory cardiovascular risk factors in hemodialysis patients.

Kaysen GA, Levin NW, Mitch WE, Chapman AL, Kubala L, Eiserich JP.

Blood Purif. 2006;24(5-6):508-16. Epub 2006 Oct 23.

PMID:
17077623
9.

Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.

Loricchio ML, Cianfrocca C, Pasceri V, Bianconi L, Auriti A, Calo L, Lamberti F, Castro A, Pandozi C, Palamara A, Santini M.

Am J Cardiol. 2007 May 15;99(10):1421-4. Epub 2007 Apr 5.

PMID:
17493472
10.

C-reactive protein and low albumin are predictors of morbidity and cardiovascular events in chronic kidney disease (CKD) 3-5 patients.

Soriano S, González L, Martín-Malo A, Rodríguez M, Aljama P.

Clin Nephrol. 2007 Jun;67(6):352-7.

PMID:
17598370
11.

Independent and joint associations of nutritional status indicators with mortality risk among chronic hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS).

Lopes AA, Bragg-Gresham JL, Elder SJ, Ginsberg N, Goodkin DA, Pifer T, Lameire N, Marshall MR, Asano Y, Akizawa T, Pisoni RL, Young EW, Port FK.

J Ren Nutr. 2010 Jul;20(4):224-34. doi: 10.1053/j.jrn.2009.10.002. Epub 2010 Jan 8.

PMID:
20060319
12.

The prognostic value of C-reactive protein in long-term care patients requiring prolonged mechanical ventilation.

Sierros V, Fleming R, Cascioli M, Brady T.

Chron Respir Dis. 2009;6(3):149-55. doi: 10.1177/1479972309104660.

PMID:
19643829
13.

Oxidized high-density lipoprotein is associated with protein-energy wasting in maintenance hemodialysis patients.

Honda H, Ueda M, Kojima S, Mashiba S, Suzuki H, Hosaka N, Hirai Y, Nakamura M, Nagai H, Kato N, Mukai M, Watanabe M, Takahashi K, Shishido K, Akizawa T.

Clin J Am Soc Nephrol. 2010 Jun;5(6):1021-8. doi: 10.2215/CJN.06110809. Epub 2010 Apr 15.

14.

Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.

Dosh K, Berger PB, Marso S, van Lente F, Brennan DM, Charnigo R, Topol EJ, Steinhubl S.

Circ Cardiovasc Interv. 2009 Dec;2(6):503-12. doi: 10.1161/CIRCINTERVENTIONS.109.879312. Epub 2009 Nov 17.

15.

Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.

Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.

Am J Kidney Dis. 2009 Jun;53(6):1024-33. doi: 10.1053/j.ajkd.2009.02.008. Epub 2009 Apr 25.

PMID:
19394732
16.

Significance of high C-reactive protein levels in pre-dialysis patients.

Ortega O, Rodriguez I, Gallar P, Carreño A, Ortiz M, Espejo B, Jimenez J, Gutierrez M, Oliet A, Vigil A.

Nephrol Dial Transplant. 2002 Jun;17(6):1105-9.

PMID:
12032204
17.

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.

Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R; RISCAVID Study Group.

Nephrol Dial Transplant. 2008 Jul;23(7):2337-43. doi: 10.1093/ndt/gfm951. Epub 2008 Feb 27.

PMID:
18305316
18.

Elevated cardiac troponin T in predialysis patients is associated with inflammation and predicts mortality.

Löwbeer C, Stenvinkel P, Pecoits-Filho R, Heimbürger O, Lindholm B, Gustafsson SA, Seeberger A.

J Intern Med. 2003 Feb;253(2):153-60.

19.

Fasting glucose levels in predicting 1-year all-cause mortality in patients who do not have diabetes and are on maintenance hemodialysis.

Lin-Tan DT, Lin JL, Wang LH, Wang LM, Huang LM, Liu L, Huang JY, Huang YL.

J Am Soc Nephrol. 2007 Aug;18(8):2385-91. Epub 2007 Jun 28.

20.

Association between C-reactive protein and clinical outcomes in peritoneal dialysis patients.

Avram MM, Fein PA, Paluch MM, Schloth T, Chattopadhyay J.

Adv Perit Dial. 2005;21:154-8.

PMID:
16686309

Supplemental Content

Support Center